Drug Profile
Ostabolin topical - Zelos Therapeutics
Alternative Names: Cyclic hPTH-(1-31)-NH2 topical; Ostabolin-C gel; Parathyroid hormone analogue topical - Zelos TherapeuticsLatest Information Update: 13 Oct 2009
Price :
$50
*
At a glance
- Originator Zelos Therapeutics Inc
- Class Osteoporosis therapies; Peptide fragments; Peptide hormones
- Mechanism of Action Calcitriol receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Psoriasis
Most Recent Events
- 09 Feb 2006 Zelos Therapeutics Inc. has completed enrolment in a phase II trial for Psoriasis in Canada
- 31 Aug 2005 Phase-II clinical trials in Psoriasis in Canada (Topical)
- 30 Jun 2005 Phase-I clinical trials in Psoriasis in Canada (Topical)